Veru Inc. (VERU) Stock Price & Analysis
Veru Inc. (VERU) fell 0.38% to USD 2.64 as of September 8, 2026 at 08:17 UTC, according to Nexqual real-time market data.
VERU last closed at USD 2.64; the session ranged USD 2.64–2.73 on volume of 143,543 shares. Market capitalization is —, with a 52-week range of USD 2.05–7.33 (NCM). Source: Nexqual, September 8, 2026 at 08:17 UTC.
Key Statistics (as of September 8, 2026 at 08:17 UTC)
| Price | USD 2.64 |
|---|---|
| Change | ▼ 0.38% (down) |
| Previous Close | USD 2.64 |
| Open | USD 2.64 |
| Day Range | USD 2.64 – 2.73 |
| 52-Week Range | USD 2.05 – 7.33 |
| Volume | 143,543 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (VERU)
Nexqual's technical model rates VERU "NEUTRAL" based on 3 bullish and 2 bearish signals across 128 daily candles, as of September 8, 2026 at 08:17 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.59 (neutral) |
| vs SMA50 | Above (USD 2.59) |
| MACD | 0.04 (positive) |
From Veru Inc.'s Latest SEC 10-K Filing (filed 2025-12-17)
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GLSI | Greenwich LifeSciences, Inc. | USD 15.95 | ▲ 1.33% |
| FLNA | Filana Therapeutics, Inc. | USD 0.82 | ▼ 4.64% |
| OCGN | Ocugen, Inc. | USD 1.36 | ▲ 3.03% |
| TTOO | T2 Biosystems, Inc. | USD 0 | ▲ 0% |
| AVXL | Anavex Life Sciences Corp. | USD 2.86 | ▼ 1.04% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:17 UTC. This page is informational and not investment advice.